Sign In

XiangQian Lin

Global Life Sciences Entrepreneur, Esco Lifesciences Group Chairman/CEO, EVX Chairman, Carmine Founding CEO

XiangQian Lin embodies the spirit of innovation and entrepreneurship within the global life sciences sector. With a mission encapsulated in his mantra, 'For the patients: making the unreasonable reasonable, one step at a time,' he has dedicated his career to transforming scientific concepts into commercial realities. XiangQian is a testament to the power of vision, persistence, and collaboration, attributes that have driven him to remarkable success since his teenage years.

Born with a unique aptitude for business and finance, XiangQian achieved financial independence at the tender age of 13. He went on to earn a Bachelor of Science in Economics and Finance from the prestigious Wharton School at the University of Pennsylvania, establishing a strong foundation that would support his future endeavors. His educational journey was enriched by his time at Raffles Institution, where he honed not only his academic prowess but also his leadership skills.

XiangQian's career is distinguished by his role as the Group President and CEO of Esco, a global life sciences and medical technology company that he has significantly transformed since 2000. Under his visionary leadership, Esco has evolved into Singapore’s leading homegrown life sciences firm, with operations spanning across the US, Europe, and China, and a workforce exceeding 1,500 employees. The company has not only established itself as a profit powerhouse, growing shareholder value at an impressive compound annual growth rate (CAGR) of 32% over two decades but also achieved cumulative revenues exceeding $1 billion. Today, Esco stands as a pioneer, with its products being sold in more than 100 countries, boasting a remarkable achievement of 150,000 systems sold.

A significant milestone in XiangQian's career was the strategic expansion of Esco into the fertility technology and in vitro fertilization (IVF) market, driven by his personal experience as a former infertility patient. This initiative has emerged as a crucial growth driver for the company, positioning Esco as a world leader in embryo incubation and cutting-edge time-lapse technologies that enhance the chances of successful pregnancies.

XiangQian's entrepreneurial journey doesn't stop with Esco. In 2018, he founded EVX Ventures (formerly known as Esco Ventures X), a global cross-border venture capital firm focused on the biotechnology sector. His ability to identify and cultivate promising biotech innovations has propelled EVX Ventures into a significant player within the industry, where it actively supports emerging companies aiming to revolutionize healthcare through science and technology.

Moreover, XiangQian joined forces with esteemed colleagues Harvey Lodish, Minh Le, and Jiahai Shi to establish Carmine Therapeutics in 2019. This cutting-edge biotech company is on the forefront of pioneering redosable gene therapies utilizing red blood cell extracellular vesicles and proprietary payloads. Notably, Carmine Therapeutics made headlines by securing a groundbreaking deal valued at over $900 million with Takeda Pharmaceuticals, which underscores XiangQian's sharp acumen for building impactful biotech ventures that resonate within the global healthcare landscape. Recognized as a Fierce 15 company, Carmine continues to make strides in transformative healthcare solutions.

XiangQian Lin's exceptional career trajectory reflects his unwavering commitment to advancing life sciences through collaboration, innovation, and a patient-focused approach. As he continues to drive Esco and his entrepreneurial ventures to new heights, he remains a respected figure in the biotech industry, inspiring other aspiring entrepreneurs and scientists alike through his journey of harnessing business potential for a better tomorrow.

Related Questions

How did XiangQian Lin achieve financial independence at such a young age?
What motivated XiangQian Lin to expand Esco into the fertility technologies market?
How have XiangQian Lin's experiences as a former infertility patient influenced his work in the IVF sector?
In what ways has XiangQian Lin leveraged his global networks to enhance the growth of Esco?
What strategies does XiangQian Lin employ to identify promising biotech startups for EVX Ventures?
How does XiangQian Lin envision the future of the life sciences industry evolving?
What role did XiangQian Lin play in the establishment of Carmine Therapeutics and its impact on the biotechnology landscape?
XiangQian Lin
Add to my network

Location

Cambridge, Massachusetts